drugset / Trial / NCT00934427
Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine if Vascana, a novel topical formulation of nitroglycerin, is effective in the treatment and prevention of the symptoms associated with Raynaud's Phenomenon.
Timeline
- Start
- 2009-06
- Primary completion
- 2010-06
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Nitroglycerin | Unknown | 0.9 % | Topical |
| Comparator | Nitroglycerin | Unknown | 0.5 g | Topical |